Point-of-care testing in Paediatric settings in the UK and Ireland: a cross-sectional study
Point-of-care testing in Paediatric settings in the UK and Ireland: a cross-sectional study
Background: point-of-care testing (POCT) is diagnostic testing performed at or near to the site of the patient. Understanding the current capacity, and scope, of POCT in this setting is essential in order to respond to new research evidence which may lead to wide implementation.
Methods: a cross-sectional online survey study of POCT use was conducted between 6th January and 2nd February 2020 on behalf of two United Kingdom (UK) and Ireland-based paediatric research networks (Paediatric Emergency Research UK and Ireland, and General and Adolescent Paediatric Research UK and Ireland).
Results: in total 91/109 (83.5%) sites responded, with some respondents providing details for multiple units on their site based on network membership (139 units in total). The most commonly performed POCT were blood sugar (137/139; 98.6%), urinalysis (134/139; 96.4%) and blood gas analysis (132/139; 95%). The use of POCT for Influenza/Respiratory Syncytial Virus (RSV) (45/139; 32.4%, 41/139; 29.5%), C-Reactive Protein (CRP) (13/139; 9.4%), Procalcitonin (PCT) (2/139; 1.4%) and Group A Streptococcus (5/139; 3.6%) and was relatively low. Obstacles to the introduction of new POCT included resources and infrastructure to support test performance and quality assurance.
Conclusions: this survey demonstrates significant consensus in POCT practice in the UK and Ireland but highlights specific inequity in newer biomarkers, some which do not have support from national guidance. A clear strategy to overcome the key obstacles of funding, evidence base, and standardising variation will be essential if there is a drive toward increasing implementation of POCT.
Data collection, Health services research, Molecular biology, Technology
Pandey, Meenu
7c09ee6f-74d7-44f2-a7e9-d9561709e4a9
Lyttle, Mark D
8b37d5d4-9dd1-4dfa-b251-7b560f4994c7
Cathie, Katrina
4b772af2-4b34-45d4-866a-fb934376e1cd
Munro, Alasdair
59dacf7d-5977-49c4-b562-b2c719c9dcf4
Waterfield, Thomas
ea6cf9d4-b8a9-4303-b332-283a1a261aca
Roland, Damian
bac42549-2249-4b39-b272-4d11f451574a
11 January 2022
Pandey, Meenu
7c09ee6f-74d7-44f2-a7e9-d9561709e4a9
Lyttle, Mark D
8b37d5d4-9dd1-4dfa-b251-7b560f4994c7
Cathie, Katrina
4b772af2-4b34-45d4-866a-fb934376e1cd
Munro, Alasdair
59dacf7d-5977-49c4-b562-b2c719c9dcf4
Waterfield, Thomas
ea6cf9d4-b8a9-4303-b332-283a1a261aca
Roland, Damian
bac42549-2249-4b39-b272-4d11f451574a
Pandey, Meenu, Lyttle, Mark D, Cathie, Katrina, Munro, Alasdair, Waterfield, Thomas and Roland, Damian
,
GAPRUKI, PERUKI
(2022)
Point-of-care testing in Paediatric settings in the UK and Ireland: a cross-sectional study.
BMC Emergency Medicine, 22 (1), [6].
(doi:10.1186/s12873-021-00556-7).
Abstract
Background: point-of-care testing (POCT) is diagnostic testing performed at or near to the site of the patient. Understanding the current capacity, and scope, of POCT in this setting is essential in order to respond to new research evidence which may lead to wide implementation.
Methods: a cross-sectional online survey study of POCT use was conducted between 6th January and 2nd February 2020 on behalf of two United Kingdom (UK) and Ireland-based paediatric research networks (Paediatric Emergency Research UK and Ireland, and General and Adolescent Paediatric Research UK and Ireland).
Results: in total 91/109 (83.5%) sites responded, with some respondents providing details for multiple units on their site based on network membership (139 units in total). The most commonly performed POCT were blood sugar (137/139; 98.6%), urinalysis (134/139; 96.4%) and blood gas analysis (132/139; 95%). The use of POCT for Influenza/Respiratory Syncytial Virus (RSV) (45/139; 32.4%, 41/139; 29.5%), C-Reactive Protein (CRP) (13/139; 9.4%), Procalcitonin (PCT) (2/139; 1.4%) and Group A Streptococcus (5/139; 3.6%) and was relatively low. Obstacles to the introduction of new POCT included resources and infrastructure to support test performance and quality assurance.
Conclusions: this survey demonstrates significant consensus in POCT practice in the UK and Ireland but highlights specific inequity in newer biomarkers, some which do not have support from national guidance. A clear strategy to overcome the key obstacles of funding, evidence base, and standardising variation will be essential if there is a drive toward increasing implementation of POCT.
Text
s12873-021-00556-7
- Version of Record
More information
Accepted/In Press date: 10 November 2021
Published date: 11 January 2022
Additional Information:
Funding Information:
The following individuals acted as site study leads for PERUKI and/or GAPRUKI in their institution, as listed: Adrian Boyle, Peter Heinz (Addenbrooke?s Hospital, Cambridge, England); Shrouk Messahel, Dan Hawcutt (Alder Hey Children?s Hospital NHS Foundation Trust, Liverpool, England); Caroline Ponmani (Barking, Havering & Redbridge University Hospitals NHS Trust, England); Chris Bird, Deepthi Jyothish (Birmingham Children?s Hospital, Birmingham, England); Catherine Williams (Bolton NHS Foundation Trust, Bolton, England); Ronan O?Sullivan (Bon Secours Hospital, Cork, Ireland); Elizabeth Jones (Bradford Royal Infirmary, Bradford, England); Mark Lyttle, Nwanneka Sargant (Bristol Royal Hospital for Children Bristol, England); James Ross (Chelsea & Westminster NHS Foundation Trust, London, England); Michael Barrett, Sinead Harty (Children?s Health Ireland at Crumlin, Dublin, Ireland); Turlough Bolger, David Coghlan (Children?s Health Ireland at Tallaght, Dublin, Ireland); Patrick Fitzpatrick, Conor Hensey (Children?s Health Ireland at Temple Street, Dublin, Ireland); Tim Hussan (County Durham & Darlington NHS Foundation Trust, England); Kate Charlick (Derriford Hospital, Plymouth, England); William Verling (Dorset County Hospital, Dorset, England); Peter Christian (East Kent Hospital, England); Matthew Clark (East Sussex NHS Health Trust, England); Bhavni Shah (Epsom General Hospital, Epsom, England); John Criddle, Ronny Cheung (The Evelina London Children?s Hospital, London, England); Roger Alcock (Forth Valley Hospital, Larbert, Scotland); Patrick Aldridge (Frimley Park Hospital, Frimley, England); Russell Peek (Gloucestershire Hospitals NHS Foundation Trust, Gloucester, England).
Publisher Copyright:
© 2021, The Author(s).
Copyright:
Copyright 2022 Elsevier B.V., All rights reserved.
Keywords:
Data collection, Health services research, Molecular biology, Technology
Identifiers
Local EPrints ID: 455879
URI: http://eprints.soton.ac.uk/id/eprint/455879
ISSN: 1471-227X
PURE UUID: d04f77aa-71d2-4e27-be0f-2bae2a4a82cf
Catalogue record
Date deposited: 07 Apr 2022 16:41
Last modified: 23 Nov 2024 03:00
Export record
Altmetrics
Contributors
Author:
Meenu Pandey
Author:
Mark D Lyttle
Author:
Katrina Cathie
Author:
Alasdair Munro
Author:
Thomas Waterfield
Author:
Damian Roland
Corporate Author: GAPRUKI, PERUKI
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics